DiscoverWSJ What’s NewsAssessing Covid-19 Vaccine Efficacy Against the Omicron Variant
Assessing Covid-19 Vaccine Efficacy Against the Omicron Variant

Assessing Covid-19 Vaccine Efficacy Against the Omicron Variant

Update: 2021-12-03
Share

Description

A.M. Edition for Dec. 3. As countries detect more cases of the Omicron variant of Covid-19 that was first identified in southern Africa, WSJ's Joanna Sugden discusses how researchers and drugmakers are racing to figure out how effective the current vaccines are against the new strain. Peter Granitz hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Assessing Covid-19 Vaccine Efficacy Against the Omicron Variant

Assessing Covid-19 Vaccine Efficacy Against the Omicron Variant

The Wall Street Journal